In the BioHarmony Drug Report Database

"Preview" Icon

Sebelipase alfa

Kanuma (sebelipase alfa) is an enzyme pharmaceutical. Sebelipase alfa was first approved as Kanuma on 2015-08-28. It has been approved in Europe to treat inborn errors lipid metabolism.

 

Trade Name

 

Kanuma
 

Common Name

 

sebelipase alfa
 

ChEMBL ID

 

CHEMBL3039537
 

Indication

 

inborn errors lipid metabolism
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Sebelipase alfa structure rendering